ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Aug 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
September 2026
Fusion Science and Technology
August 2026
Latest News
Second round of Launch Pad selections includes eight newcomers
The National Reactor Innovation Center at Idaho National Laboratory has announced 13 project selections across 12 companies for the Nuclear Energy Launch Pad, a Department of Energy–led program that integrates reactor and fuel facility authorization, testing, and deployment support for private nuclear developers.
The Launch Pad emerged from the Reactor Pilot Program and Fuel Line Pilot Program.
According to INL, projects selected include reactor development and nuclear fuel cycle advancements, including fabrication, enrichment, and conversion technologies.
Masahiro Saito
Fusion Science and Technology | Volume 41 | Number 3 | May 2002 | Pages 399-403
Biology | Proceedings of the Sixth International Conference on Tritium Science and Technology Tsukuba, Japan November 12-16, 2001 | doi.org/10.13182/FST02-A22619
Articles are hosted by Taylor and Francis Online.
In a series of experiments, the dosimetry of OBT in the mice supplied with THO or OBT directly or indirectly from their mothers was studied. In the offspring mice nursed by mother mice supplied with THO as drinking water, the largest contribution of OBT to the total accumulated dose was found in the brain. The percent contribution of OBT to the total dose distributed between 17 and 42% among various soft tissues. The OBT localization to cell nuclei increases the microscopic dose to cell nuclei by a factor of 3 – 6 in the case of DNA-bound tritium in comparison with the dose estimated from the tissue-averaged tritium concentration. The tritium localization is of less importance in the case of protein-bound tritium. The blood level tritium was found to be useful and convenient for OBT dosimetry in a practical case of radiation protection of humans after acute and chronic intake of tritium. A new technique was developed to isolate mouse red bone marrow from tibia. A model experiment using mice has shown that the dose to red bone marrow in the case of oral THO intake was lower than the dose estimated for the blood pool.